QIAGEN N.V.: QIAGEN launches QIAstat-Dx in Japan with respiratory panel for syndromic testing
Venlo, the Netherlands, April 24, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its QIAstat-Dx syndromic testing solution is expected to be available
Source: finanznachrichten.de